Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Preparation and in vitro evaluation of polycaprolactone/PEG/bioactive glass nanopowders nanocomposite membranes for GTR/GBR applications.

Soltani Dehnavi S., Mehdikhani M., Rafienia M., Bonakdar S.

Laboratory Study on Face & Skin, published in Mater Sci Eng C Mater Biol Appl (2018) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Mater Sci Eng C Mater Biol Appl (2018)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
29853087
DOI
10.1016/j.msec.2018.04.065
Citations
32

Abstract (original English)

In the present study, nanocomposite membranes are investigated using poly-ε-caprolactone (PCL), polyethylene glycol (PEG) and bioactive glass nanopowders (BGs) synthesized via solvent casting method with different reinforcement rates of BGs consisting of 3, 5 and 7 wt% for regenerating the periodontal tissue in vitro. These prepared membranes were evaluated by a vast range of essential tests; including Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), Transmition-electron microscopy (TEM), tensile testing before and after soaking in PBS solution, degradation and contact angle assessments as well as cell culture assays. In spite of the fact that the percentage of Cu incorporated into BGs was trivial, this negligible amount exerted major cytotoxic impact upon cells during in vitro cell tests. According to the results, the blended-membrane contained 7 wt% copper-free BGs indicated optimum characteristics including satisfactory mechanical and biodegradation features, more wettable surface, higher proliferation rates of adipose-derived stem cells (ADSCs), superior ALP activity and brilliant bone mineralization capacity which was confirmed by Alizarin red assay. As a consequence, it can be used as a desirable candidate for guided tissue/bone regeneration (GTR/GBR) to accelerate bone tissue healing.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Biocompatible MaterialsBone RegenerationGlassGuided Tissue RegenerationMicroscopy, Electron, ScanningMicroscopy, Electron, TransmissionNanocompositesPolyestersPolyethylene GlycolsSpectroscopy, Fourier Transform Infrared

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research